Jump to main content

Jump to global navigation

Jump to local navigation

Jump to header utility

Jump to footer

HOME > AboutUs > Press Releases

Press Release

  • AboutUs
  • Message from President
  • Corporate Philosophy
  • Long-term Business Prospect
  • Corporate Brand
  • Corporate Governance
  • About Toray
  • Press Release
  • Latest News
  • Archive by Keywords
  • Fibers & Textiles
  • Plastics
  • Films
  • Chemicals
  • Water Treatment Membranes & Related Equipments
  • Carbon Fibers & Composite Materials
  • Electronics & Information Related Products
  • Pharmaceuticals & Medical Products
  • Amenity Products
  • Fashion & Apparel
  • Housing & Engineering
  • Information, Services & Other Products
  • Management
  • Environment
  • Research and Development
  • Community Relations
  • Affiliated Companies
  • Others
  • Archives by Year
  • Events & Sports
  • Activities of the TORAY Group
  • Our People

Archives by Keywords

Pharmaceuticals & Medical Products

Oct. 16, 2009
Additional indication for the natural-type interferon beta preparation Feron® against “chronic hepatitis C on concomitant use with ribavirin”
Mar. 23, 2009
Launch of REMITCH® CAPSULES 2.5 µg , new oral antipruritus drug
Mar. 11, 2009
Initiation of co-development of a β3-adrenoceptor agonist
Feb. 25, 2009
Toray begins clinical trial of PEG-interferon Beta (TRK-560) in Japan
Jan. 21, 2009
Manufacturing and marketing approval for REMITCH® CAPSULES 2.5 µg , oral antipruritus drug, in Japan
Dec. 18, 2007
Announcement of the Launch of the Pulmonary Arterial Hypertension Agent Careload® LA Tablets 60¯g in Japan
Oct. 22, 2007
Announcement of the Acquisition of Marketing Approval for the Pulmonary Arterial Hypertension Agent Careload® LA Tablets 60µg in Japan
-- The World First Oral Prostacyclin (PGI2) Derivative Prolonged Release --
Jun. 29, 2007
Torii, Toray starts to Co-Promote Hemoperfusion absorption column Toraymyxin* for removing endotoxin
Nov. 28, 2006
New Drug Application of Antipruritic Agent “TRK-820” for the Treatment of Severe Pruritus in Hemodialysis Patients in Japan
Sep. 4, 2006
Toray, JT, Torii Agree to Co-Develop and Market TRK-820 Antipruritus Drug for Hepatic Disease Patients in Japan
Dec. 5, 2005
Toray, DNA Chip Research to Jointly Develop New DNA Microarrays
-- Aiming for De Facto Standard With Commercialization of High Performance DNA Chips--
Oct. 31, 2005
Maruho and Toray Partner on Phase III Therapeutic for Dialysis Patients in Europe
Apr. 07, 2005
Toray and Takeda to Jointly Develop and Market an Investigational Compound for Frequent Urination/Urinary Incontinence
Mar. 31, 2005
Maruho, Toray Agree to Co-Develop and Market New Atopic Dermatitis Drug in Japan
Mar. 16, 2005
Toray, Japan Tobacco, Torii Pharmaceutical Agree to Co-Develop and Market
New Antipruritus Drug in Hemodialysis Patients in Japan

PAGETOP